BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guo YR, Liu XM, Wang GX. Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis. World J Diabetes 2023; 14(2): 120-129 [PMID: 36926660 DOI: 10.4239/wjd.v14.i2.120]
URL: https://www.wjgnet.com/1948-9358/full/v14/i2/120.htm
Number Citing Articles
1
Bin Xia, Qiangsheng He, Fang Gao Smith, V. Georgios Gkoutos, Krishnarajah Nirantharakumar, Zi Chong Kuo, Danni Wang, Qi Feng, Eddie C. Cheung, Lunzhi Dai, Junjie Huang, Yuanyuan Yu, Wenbo Meng, Xiwen Qin, Jinqiu Yuan. Individualized prevention of proton pump inhibitor related adverse events by risk stratificationNature Communications 2024; 15(1) doi: 10.1038/s41467-024-48007-8
2
Dmitry I. Trukhan, Sergej N. Filimonov. Cardiovascular risk with long-term use of proton pump inhibitors: myth or reality. A reviewConsilium Medicum 2024; 26(1): 55 doi: 10.26442/20751753.2024.1.202532
3
Santenna Chenchula, Phulen Sharma, Mohan Krishna Ghanta, Krishna Chaitanya Amerneni, Padmavathi Rajakarunakaran, Pavani Saggurthi, Madhu Bhargavi Chandra, Rupesh Gupta, Madhavrao Chavan. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Meta-AnalysisCurrent Diabetes Reviews 2024; 20(10) doi: 10.2174/0115733998254869231101095222
4
D. I. Trukhan, I. A. Viktorova. Side effects of proton pump inhibitors with long-term use: focus on the urinary systemMedical alphabet 2024; (5): 36 doi: 10.33667/2078-5631-2024-5-36-42